Global Bioabsorbable Stents Market Hits $150.3 Million in 2025 with 5.0% CAGR

Bioabsorbable stents market was valued at $150.3 million in 2025 and is projected to reach $242.9 million by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035). The rising adoption of bioabsorbable stents in cardiovascular and vascular treatments is transforming interventional procedures by offering temporary vessel support without leaving permanent implants. These stents gradually dissolve within the body after restoring blood flow, reducing long-term complications associated with traditional metallic stents. Bioabsorbable stents are widely used in coronary artery disease, peripheral artery disease, and pediatric cardiology, supporting safer and more natural vessel healing.

Browse the full report description of “Bioabsorbable Stents Market Size, Share & Trends Analysis Report by Polymer Type (Poly (L-Lactic Acid) PLLA, Tyrosine Polycarbonate Polymer, Poly (Caprolactone) (PCL), Poly (Anhydride Ester) Salicylic Acid) By Application (Coronary Artery Diseases, Peripheral Artery Diseases, and others) By End-User (Hospitals, Cardiac Centers, and Others), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/bioabsorbable-stents-market

The global bioabsorbable stents market is witnessing steady growth, driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in biodegradable materials such as polylactic acid (PLA), magnesium alloys, and polymer-based scaffolds. Growing awareness among clinicians and patients regarding the benefits of temporary implants, along with improving regulatory approvals, is further accelerating market adoption.

Key trends shaping the bioabsorbable stents landscape include continuous innovation in material science, improved drug-eluting bioresorbable scaffolds, enhanced imaging compatibility, and the expansion of clinical trials demonstrating long-term safety and efficacy. Additionally, supportive healthcare policies, rising healthcare expenditure, and increasing investments by medical device companies are fueling market expansion across both developed and emerging economies.

Key Innovators Driving eHealth Transformation

The key players in the global bioabsorbable stent market include Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., MicroPort Scientific Corp., and Terumo Corp., among others. These companies are focused on developing next-generation bioresorbable vascular scaffolds, bioabsorbable polymer coatings, and biodegradable materials to improve long-term patient outcomes and reduce complications associated with permanent metallic implants.

• In November 2025, Royal Philips launched Philips Image Management 15, the next-generation Philips Vue PACS, featuring a zero-footprint web diagnostic viewer that allows radiologists to access and interpret medical images via a standard web browser. With a redesigned user interface, it delivers the capabilities of a full desktop workstation while enhancing mobility, scalability, and collaboration, reducing IT complexity, and freeing up clinical teams’ time.
• In November 2024, R3 Vascular Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial for its MAGNITUDE® drug-eluting bioresorbable scaffold for the treatment of below-the-knee (BTK) peripheral arterial disease. The IDE approval permits the company to conduct the ELITE-BTK trial, which plans to enroll up to 264 patients across multiple international clinical sites starting in early 2025. The study is intended to assess the device’s safety and performance, including its ability to provide temporary vessel support and undergo gradual resorption within the body.

 Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • by Polymer Type
  • by Application
  • by End-Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., MicroPort Scientific Corp., and Terumo Corp., among others. 

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Bioabsorbable Stents Market Report Segment

By Polymer Type

• Poly (L-Lactic Acid) PLLA
• Tyrosine Polycarbonate Polymer
• Poly (Caprolactone) (PCL)
• Poly (Anhydride Ester) Salicylic Acid)

By Application

• Coronary Artery Disease
• Peripheral Artery Diseases
• Others

By End-Users

• Hospitals
• Cardiac Centers
• Others

Bioabsorbable Stents Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioabsorbable-stents-market